基于影像组学的人工智能模型在结直肠癌诊断、转移检测、预后及治疗反应预测中的应用
本文综述了基于不同影像模态的影像组学人工智能模型在结直肠癌诊断与分期、良恶性病变鉴别、淋巴结及肝转移检测、疗效与预后预测中的最新证据,并讨论了临床转化面临的图像采集差异、可重复性、标准化缺乏及外部验证有限等挑战。
要点
- 影像组学与影像基因组学可高通量量化医学图像特征,无创刻画肿瘤异质性。
- 基于影像组学的人工智能方法在结直肠癌诊断与分期、良恶性鉴别、淋巴结及肝转移检测、疗效与预后预测方面显示出较大潜力。
- 临床转化面临图像采集差异、可重复性问题、标准化缺乏及外部验证有限等挑战。
核心结论
- 基于影像组学的人工智能方法在提高结直肠癌诊断与分期准确性、鉴别良恶性病变、辅助检测淋巴结及肝转移、预测治疗效应与预后方面显示出较大潜力。
- 随着机器学习与深度学习算法的进展,影像组学有望对结直肠癌的个体化治疗产生重要影响,并有助于未来更准确、更个体化的临床决策。
研究设计与样本
- 本文为综述,汇总了基于不同影像模态的影像组学模型在结直肠癌中临床应用的最新证据。
- 原文未报告检索数据库、检索时间范围、纳入文献数量及证据分级方法。
临床应用与阅片要点
- 影像组学与影像基因组学可高通量量化医学图像特征,提供无创刻画肿瘤异质性并洞察其生物学基础的手段。
- 基于影像组学的人工智能方法可用于结直肠癌诊断与分期、良恶性病变鉴别、淋巴结及肝转移检测、疗效与预后预测。
局限性
- 临床转化面临图像采集差异的问题。
- 存在可重复性问题。
- 缺乏标准化。
- 外部验证有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Colorectal cancer (CRC) is the third most common cause of cancer-related morbidity and mortality in the world. Radiomics and radiogenomics are utilized for the high-throughput quantification of features from medical images, providing non-invasive means to characterize cancer heterogeneity and gain insight into the underlying biology. Such radiomics-based artificial intelligence (AI)-methods have demonstrated great potential to improve the accuracy of CRC diagnosis and staging, to distinguish between benign and malignant lesions, to aid in the detection of lymph node and hepatic metastasis, and to predict the effects of therapy and prognosis for patients. This review presents the latest evidence on the clinical applications of radiomics models based on different imaging modalities in CRC. We also discuss the challenges facing clinical translation, including differences in image acquisition, issues related to reproducibility, a lack of standardization, and limited external validation. Given the progress of machine learning (ML) and deep learning (DL) algorithms, radiomics is expected to have an important effect on the personalized treatment of CRC and contribute to a more accurate and individualized clinical decision-making in the future.
引用
- Elahi R, Karami P, Amjadzadeh M, et al. Radiomics-based artificial intelligence (AI) models in colorectal cancer (CRC) diagnosis, metastasis detection, prognosis, and treatment response prediction. Abdom Radiol (NY). 2025. PMID: 40991016. doi:10.1007/s00261-025-05201-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。